News & Events

Press Releases

On the 28th March 2022, OncoArendi changed its name to Molecure

Drug Candidate OATD-01 may find use in treatment of pulmonary fibrosis in patients who have survived a new coronavirus infection (COVID-19)

24 March 2020

National Center for Research and Development (NCBR) funds OncoArendi Therapeutics’ new research platform of innovative anticancer drugs targeting deubiquitinase proteins.

31 January 2020

New Head of Research (Chief Scientific Officer) at OncoArendi

22 October 2019

First clinical proof-of-concept for arginase inhibitors in cancer immunotherapy

1 October 2019

OncoArendi Therapeutics at the 2019 BIO International Convention in USA

31 May 2019

OncoArendi at the conference “WSE Innovation Day”

3 April 2019

Sign up for the latest News & Events

Events & Presentations

Fibrosis and Tissue Repair: From Molecules and Mechanics to Therapeutic Approaches – February 19-23, 2020 | Victoria, BC, Canada

27 February 2020

EFMC-ASMC’19 – September 1-5, 2019 | Athens, Greece

11 September 2019

ACS National Meeting & Expo – August 25 – 29, 2019 | San Diego, CA

4 September 2019

ATS- International Conference – Dallas, 17-22.05.2019

22 May 2019

EFMC – YMCS – Young Medicinal Chemist Symposium – Ljubljana 02-06.09.2018

17 September 2018

EFMC – International Symposium on Medicinal Chemistry – Ljubljana 02-06.09.2018

17 September 2018
This site is registered on wpml.org as a development site.